31 related articles for article (PubMed ID: 2530268)
1. Effects of the neutral endopeptidase inhibitor thiorphan on cardiovascular and renal function in cirrhotic rats.
Park KS; Li Y; Zhang Y; Gerbes AL; Liu H; Swain MG; Lee SS
Br J Pharmacol; 2003 May; 139(1):81-8. PubMed ID: 12746226
[TBL] [Abstract][Full Text] [Related]
2. The effect of atrial natriuretic peptide infusion on intestinal injury in septic shock.
Elbaradey GF; Elshmaa NS; Hodeib H
J Anaesthesiol Clin Pharmacol; 2016; 32(4):470-475. PubMed ID: 28096577
[TBL] [Abstract][Full Text] [Related]
3. Increased cardiac endocrine activity after common bile duct ligation in the rabbit. Atrial endocrine cells in obstructive jaundice.
Pereira JA; Torregrosa MA; Martínez-Ródenas F; Clària J; Pallarés L; Gubern JM; Ruano-Gil D; Sitges-Serra A
Ann Surg; 1994 Jan; 219(1):73-8. PubMed ID: 8297180
[TBL] [Abstract][Full Text] [Related]
4. Renal tubular responsiveness to atrial natriuretic peptide in sodium-retaining chronic caval dogs. A possible role for kinins and luminal actions of the peptide.
Legault L; Cernacek P; Levy M; Maher E; Farber D
J Clin Invest; 1992 Oct; 90(4):1425-35. PubMed ID: 1328299
[TBL] [Abstract][Full Text] [Related]
5. Effect of atrial natriuretic peptide on arterial pressure and renal function in cirrhotic rats with ascites.
López C; Jiménez W; Arroyo V; Gaya J; Rivera F; Rodés J
Rev Esp Fisiol; 1988 Sep; 44(3):265-72. PubMed ID: 2976517
[TBL] [Abstract][Full Text] [Related]
6. Atrial natriuretic peptide in rats with experimental cirrhosis of the liver without ascites.
Olivera A; Gutkowska J; Rodriguez-Puyol D; Fernandez-Cruz A; López-Novoa JM
Endocrinology; 1988 Mar; 122(3):840-6. PubMed ID: 2963741
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
8. Renal insensitivity to atrial natriuretic peptide in patients with cirrhosis and ascites. Effect of increasing systemic arterial pressure.
Ginès P; Titó L; Arroyo V; Llach J; Salmerón JM; Ginès A; Jiménez W; Badalamenti S; Rivera F; Rodés J
Gastroenterology; 1992 Jan; 102(1):280-6. PubMed ID: 1290472
[TBL] [Abstract][Full Text] [Related]
9. Effects of high dose atrial natriuretic peptide on renal haemodynamics, sodium handling and hormones in cirrhotic patients with and without ascites.
Jespersen B; Eiskjaer H; Jensen JD; Mogensen CE; Sørensen SS; Pedersen EB
Scand J Clin Lab Invest; 1995 Jul; 55(4):273-87. PubMed ID: 7569729
[TBL] [Abstract][Full Text] [Related]
10. Role of altered systemic hemodynamics in the blunted renal response to atrial natriuretic peptide in rats with cirrhosis and ascites.
López C; Jiménez W; Arroyo V; La Villa G; Gaya J; Clària J; Rivera F; Rodés J
J Hepatol; 1989 Sep; 9(2):217-26. PubMed ID: 2530268
[TBL] [Abstract][Full Text] [Related]
11. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
Jespersen B
Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
[TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic peptide: renal effects in cirrhosis of the liver.
Levy M
Semin Nephrol; 1997 Nov; 17(6):520-9. PubMed ID: 9353863
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
